Cover Image

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice

Saved in:

Bibliographic Details
Main Authors:	Fei Zheng (Author), Shanshan Xing (Author), Zushun Gong (Author), Wei Mu (Author), Qichong Xing (Author)
Format:	Book
Published:	Hindawi Limited, 2014-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Increased Expression of Chitinase 3-Like 1 in Aorta of Patients with Atherosclerosis and Suppression of Atherosclerosis in Apolipoprotein E-Knockout Mice by Chitinase 3-Like 1 Gene Silencing
by: Zushun Gong, et al.
Published: (2014)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
by: Karen Alejandra Méndez-Lara, et al.
Published: (2020)

Cholesterol-lowering pattern affects the progression of atherosclerosis in apolipoprotein E deficient mice
by: Yusuke Masuda, et al.
Published: (2016)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
by: Bin Fang, et al.
Published: (2018)

Activation of CREB Protein With Tabersonine Attenuates STAT3 During Atherosclerosis in Apolipoprotein E-Deficient Mice
by: Sen Shi, et al.
Published: (2020)

Isoquinoline Alkaloids and Indole Alkaloids Attenuate Aortic Atherosclerosis in Apolipoprotein E Deficient Mice: A Systematic Review and Meta-Analysis
by: Yibing Zhang, et al.
Published: (2018)

A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice
by: Jade Gauvin, et al.
Published: (2023)

Biochemical Evidence of Atherosclerosis Progression Mediated by Increased Oxidative Stress in Apolipoprotein E-Deficient Spontaneously Hyperlipidemic Mice Exposed to Chronic Cigarette Smoke
by: Masaru Kunitomo, et al.
Published: (2009)

Effect of Apolipoprotein E ϵ4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels
by: Ma W, et al.
Published: (2022)

Diallyl disulfide alleviates hypercholesterolemia induced by a western diet by suppressing endoplasmic reticulum stress in apolipoprotein E-deficient mice
by: Hyun Ju Kim, et al.
Published: (2023)

Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway
by: Chunping Liu, et al.
Published: (2021)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe-/- mice
by: Julia Leipner, et al.
Published: (2021)

The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation
by: Florian Kahles, et al.
Published: (2018)

Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition
by: Henrike Janssen, et al.
Published: (2015)

Apolipoprotein C-II Deficiency with Encephalopathy
by: J Gordon Millichap
Published: (2003)

Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
by: Pengfei Zuo, et al.
Published: (2017)

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
by: Preusch MR, et al.
Published: (2016)

Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
by: Getz GS, et al.
Published: (2011)

Predictor Factors of Atherosclerosis and Atherosclerosis Plaque in Rheumatoid Arthritis Patients
by: Joko Rilo Pambudi, et al.
Published: (2018)

Pomegranate Peel Extract Decreases Plaque Necrosis and Advanced Atherosclerosis Progression in Apoe-/- Mice
by: Vijayprakash Manickam, et al.
Published: (2022)

Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice
by: Andrea R. López-Pastor, et al.
Published: (2021)

Correction: Inhibition of c-Jun N-Terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice
by: Juan Wang, et al.
Published: (2022)

Pharmacological Inhibition of Lysine-Specific Demethylase 1A Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice by a Mechanism Involving Decreased Oxidative Stress and Inflammation; Potential Implications in Human Atherosclerosis
by: Simona-Adriana Manea, et al.
Published: (2022)

NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
by: Pengfei Chen, et al.
Published: (2024)

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
by: Tadayoshi Karasawa, et al.
Published: (2017)

Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice
by: Preusch MR, et al.
Published: (2015)

The Impact of Lipoproteins on Wound Healing: Topical HDL Therapy Corrects Delayed Wound Healing in Apolipoprotein E Deficient Mice
by: Stephanie C. Gordts, et al.
Published: (2014)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
by: Weijia Li, et al.
Published: (2023)

Long-term Expression of Apolipoprotein B mRNA-specific Hammerhead Ribozyme via scAAV8.2 Vector Inhibits Atherosclerosis in Mice
by: Hersharan Nischal, et al.
Published: (2013)

(-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
by: Wei Wang, et al.
Published: (2018)

Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
by: Qianxing Zhou, et al.
Published: (2011)

The sodium‐glucose co‐transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE‐deficient mice with streptozotocin‐induced diabetes
by: Masahiko Iwamoto, et al.
Published: (2022)

Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR/JAK2/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice
by: Fei Cao, et al.
Published: (2020)

Corrigendum: (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
by: Wei Wang, et al.
Published: (2018)

The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis
by: Xiao-Nan Zhang, et al.
Published: (2022)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
by: Jiang C, et al.
Published: (2021)

Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages
by: Mitsuhisa Koga, et al.
Published: (2020)

Scutellarin Suppresses NLRP3 Inflammasome Activation in Macrophages and Protects Mice against Bacterial Sepsis
by: Yi Liu, et al.
Published: (2018)

Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice
by: Victor Brito, et al.
Published: (2017)

Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
by: Jia Zhao, et al.
Published: (2023)